Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non–Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer
Virginia M. Rosen, Ines Guerra, Mary McCormack, Angélica Nogueira-Rodrigues, Andre Sasse, Veronica C. Munk, Aijing Shang
International Journal of Gynecologic Cancer Jul 2017, 27 (6) 1237-1246; DOI: 10.1097/IGC.0000000000001000